HomeAI · summaries
Storia in 9 fonti
Bristol Myers Squibb Supercharges Drug Discovery With NVIDIA AI - Bristol-Myers Squibb (NYSE:BMY)
Bristol Myers Squibb adopts NVIDIA DGX SuperPOD to train next-gen AI models and accelerate drug discovery.
Confronto fonti
6 prospettive sulla stessa storiaTimeline cronologica
- ·
biopharmadive.com
Bristol Myers to build ‘powerful’ AI factory; Samsung Biologics bids for peptide maker
Bristol Myers is the third pharmaceutical company to recently seek Nvidia’s help building a large AI data center. Elsewhere, a Novartis kidney drug gained a leg up on competitors.
- ·
statnews.com
Bristol Myers Squibb becomes latest company to claim it’s building pharma’s largest NVIDIA AI supercomputer
Bristol Myers Squibb is the third drugmaker in nine months to announce it is building the largest AI supercomputer in the life sciences industry.
- ·
endpoints.news
Bristol Myers says it will build pharma's 'most powerful' AI supercomputer with Nvidia
Bristol Myers says it will build biopharma's
- ·
channelnewsasia.com
Bristol Myers buys Nvidia's latest AI computing system for drug research
NEW YORK, July 20 : Bristol Myers Squibb said on Monday it is buying the latest-generation computing system from chip company Nvidia to support its use of artificial intelligence…
- ·
cryptobriefing.com
Nvidia partners with Bristol-Myers Squibb to build AI supercomputer for drug discovery
Bristol-Myers Squibb and Nvidia built an AI supercomputer for drug discovery that cut computing costs 55%, joining a pharma industry AI infrastructure race.
- ·
morningstar.com
Bristol Myers Squibb to Build the Most Powerful AI Factory in Life Sciences with NVIDIA
Bristol Myers Squibb to Build the Most Powerful AI Factory in Life Sciences with NVIDIA
- ·
economictimes.indiatimes.com
Bristol Myers buys Nvidia's latest AI computing system for drug research - The Economic Times
Bristol Myers Squibb is buying Nvidia's latest AI computing system. This new system will support artificial intelligence in drug discovery and development. The company expects to…
- ·
benzinga.com
Bristol Myers Squibb Supercharges Drug Discovery With NVIDIA AI - Bristol-Myers Squibb (NYSE:BMY)
Bristol Myers Squibb adopts NVIDIA DGX SuperPOD to train next-gen AI models and accelerate drug discovery.
- ·
Bristol Myers Squibb expands Nvidia partnership to supercharge its AI drug factory
Bristol Myers Squibb expands its Nvidia AI factory partnership, reporting 55% cost savings on drug discovery workloads. Here's what it means for investors.
- ·
Bristol Myers Squibb buys Nvidia's latest AI computing system for drug research
Bristol Myers Squibb acquires Nvidia's Vera Rubin DGX SuperPOD for drug discovery, becoming the first pharma company to deploy the latest AI computing
- ·
hwupgrade.it
Addio a settimane di test in laboratorio: ecco il supercomputer NVIDIA che progetta i farmaci da solo
Bristol Myers Squibb, colosso farmaceutico con sede principale negli Stati Uniti, ha annunciato un secondo NVIDIA DGX SuperPOD basato su otto sistemi DGX Vera Rubin NVL72 che sar�…